Cargando…
Potential therapies targeting nuclear metabolic regulation in cancer
The interplay between genetic alterations and metabolic dysregulation is increasingly recognized as a pivotal axis in cancer pathogenesis. Both elements are mutually reinforcing, thereby expediting the ontogeny and progression of malignant neoplasms. Intriguingly, recent findings have highlighted th...
Autores principales: | Chen, Yanjie, Xu, Jie, Liu, Xiaoyi, Guo, Linlin, Yi, Ping, Cheng, Chunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685089/ https://www.ncbi.nlm.nih.gov/pubmed/38034101 http://dx.doi.org/10.1002/mco2.421 |
Ejemplares similares
-
RNA 5-Methylcytosine Regulators Contribute to Metabolism Heterogeneity and Predict Prognosis in Ovarian Cancer
por: Xu, Jie, et al.
Publicado: (2022) -
Metabolism of Amino Acids in Cancer
por: Wei, Zhen, et al.
Publicado: (2021) -
Lipid metabolism reprogramming and its potential targets in cancer
por: Cheng, Chunming, et al.
Publicado: (2018) -
Interplay Between m(6)A RNA Methylation and Regulation of Metabolism in Cancer
por: Mobet, Youchaou, et al.
Publicado: (2022) -
Arginine metabolism: a potential target in pancreatic cancer therapy
por: Yang, Jin-Shou, et al.
Publicado: (2021)